Výsledky vyhledávání

Phase III Study Comparing Exemestane With Tamoxifen As First-Line Hormonal Treatment of Metastatic Breast Cancer in Postmenopausal Women: The European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group

Autor: Martine Piccart, Robert Paridaens, Patrick Therasse, Jan Bogaerts, David Cameron, M. Nooij, Luc Dirix, Tanja Cufer, Louk V.A.M. Beex

Publikováno v: Journal of Clinical Oncology, 26, 30, pp. 4883-90
Journal of Clinical Oncology, 26, 4883-90
Paridaens, R J, Dirix, L Y, Beex, L V, Nooij, M, Cameron, D A, Cufer, T, Piccart, M J, Bogaerts, J & Therasse, P 2008, ' Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group ', Journal of Clinical Oncology, vol. 26, no. 30, pp. 4883-90 . https://doi.org/10.1200/JCO.2007.14.4659

Purpose This phase III randomized open-label clinical trial was designed to evaluate the efficacy and safety of the steroidal aromatase inactivator exemestane versus the antiestrogen tamoxifen as first-line treatment for metastatic breast cancer (MBC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b16c472841b4f4dffd419aa7dc83c0a
https://doi.org/10.1200/jco.2007.14.4659

Zobrazit plný text záznamu

Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients

Autor: Sjoerd Rodenhuis, Nanno Mulder, W.T.A. van der Graaf, E. van der Wall, E.G.E. de Vries, W.M. Smit, M. Nooij, Pierre S. Hupperets, M. Bontenbal, Q.G.C.M. van Hoesel, Patrick Nieboer, Emile E. Voest, Hendrika Boezen

Publikováno v: Bone Marrow Transplantation, 42(7), 475-481. Nature Publishing Group
Bone marrow transplantation, 42(7), 475-481. Nature Publishing Group
Bone Marrow Transplantation, 42, 475-81
Nieboer, P, de Vries, E G E, Mulder, N H, Rodenhuis, S, Bontenbal, M, van der Wall, E, van Hoesel, Q G, Smit, W M, Hupperets, P, Voest, E E, Nooij, M A, Boezen, H M & van der Graaf, W T A 2008, ' Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients ', Bone Marrow Transplantation, vol. 42, no. 7, pp. 475-481 . https://doi.org/10.1038/bmt.2008.195
Bone Marrow Transplantation, 42, 7, pp. 475-81

Item does not contain fulltext Neutropenia following high-dose chemotherapy leads to a high incidence of infectious complications, of which central venous catheter-related infections predominate. Catheter-related infections and associated risk factor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fa0e6455ea2c9701ad10b0f007babff
https://doi.org/10.1038/bmt.2008.195

Zobrazit plný text záznamu

Doxorubicin-paclitaxel

Autor: Martine Piccart, David Miles, M. Nooij, Aaron Sulkes, Bernardo Leon Rapoport, Robert E. Coleman, Laura Biganzoli, François Delhaye, Tanja Cufer, A. Hamilton, Peter F. Bruning, Luc Duchateau

Publikováno v: Cancer. 97:40-45

BACKGROUND: The potential cardiotoxicity of the doxorubicin-paclitaxel regimen, when paclitaxel is given shortly after the end of the anthracycline infusion, is an issue of concern, as suggested by small single institution Phase II studies. METHODS:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d10a771c28a1dd65fe6740cc1419e5f
https://doi.org/10.1002/cncr.10914

Zobrazit plný text záznamu

EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx®, Doxil®) at a 6-week interval in patients with metastatic breast cancer

Autor: M. Nooij, L. Mauriac, Anne Hamilton, I. Van Hoorebeeck, Louk V.A.M. Beex, Peter F. Bruning, Ahmad Awada, Dominique de Valeriola, Robert E. Coleman, Philippe Hennebert, Laura Biganzoli, Martine Piccart

Publikováno v: Annals of Oncology. 13:910-918

Background We performed a phase I study of polyethylene glycol (pegylated, Stealth®) liposomal doxorubicin (Caelyx®, Doxil®) using a prolonged (6-week) dose interval to reduce the incidence of skin toxicity that was dose-limiting at more conventio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b5f9c964f0154e9d21fd49435364ce54
https://doi.org/10.1093/annonc/mdf157

Zobrazit plný text záznamu

The Track of a Bicycle Back Tire

Autor: Sander E. M. Nooij, R. J. C. Bosman, Steven R. Dunbar

Publikováno v: Mathematics Magazine. 74:273-287

A rider on a bicycle goes down a road, steering a path with the front tire, or perhaps just weaving back and forth. If the tires pass through a puddle, we can see from the tracks that the back tire follows a path similar to that of the front tire. Su

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::17e692ee20cd64bb4699b675113bd396
https://doi.org/10.1080/0025570x.2001.11953077

Zobrazit plný text záznamu

Searching for physics beyond the Standard Model in the decay B+ ? K+K+ ??

Autor: J. Damet, S. E. M. Nooij, A. Manara, Paula Eerola

Publikováno v: EPJ direct. 3:1-9

The observation potential of the decay B+ → K+K+π− with the ATLAS detector at LHC is described in this paper. In the Standard Model this decay mode is highly suppressed, while in models beyond the Standard Model it could be significantly enhance

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fd323b487878e3a8e1c9e3d30ebdfab1
https://doi.org/10.1007/s1010501c0007

Zobrazit plný text záznamu

Patients’ preferences for adjuvant chemotherapy in early-stage breast cancer: is treatment worthwhile?

Autor: Anne M. Stiggelbout, Job Kievit, H.-J. van Slooten, M. Nooij, J.C.J.M. de Haes, E Maartense, I M E Overpelt, Sylvia J. T. Jansen

Publikováno v: British journal of cancer, 84(12), 1577-1585. Nature Publishing Group
British Journal of Cancer

When making decisions about adjuvant chemotherapy for early-stage breast cancer, costs and benefits of treatment should be carefully weighed. In this process, patients' preferences are of major importance. The objectives of the present study were: (1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82d455320acee15a6a2443df7d3ab96d
https://doi.org/10.1054/bjoc.2001.1836

Zobrazit plný text záznamu

Unstable Preferences: A Shift in Valuation or an Effect of the Elicitation Procedure?

Autor: Anne M. Stiggelbout, M. Nooij, Evert M. Noordijk, Peter P. Wakker, Job Kievit, Sylvia J. T. Jansen

Publikováno v: Medical Decision Making, 20, 62-71. SAGE Publications Inc.

Objective. Many studies suggest that impaired health states are valued more positively when experienced than when hypothetical. This study investigated to what extent this discrepancy occurs and examined four possible explanations: non-corresponding

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e490de66a3f7145c29e9475de4b63840
https://doi.org/10.1177/0272989X0002000108

Zobrazit plný text záznamu

[Untitled]

Autor: M. Nooij, E. M. Noordijk, Job Kievit, Anne M. Stiggelbout, Sylvia J. T. Jansen

Publikováno v: Quality of Life Research. 9:603-615

In medicine, response shift refers to a change — as a result of an event such as a therapy — in the meaning of one's self-evaluation of quality of life. Due to response shift, estimates of side effects of radiotherapy may be attenuated if patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6c7091e28199ed5ce152e3879facb9b3
https://doi.org/10.1023/a:1008928617014

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání